A

Alloy Therapeutics, Inc

112 employees

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.

Investor insights

Sectors invested in

Biotechnology7

Life Science5

Therapeutics4

Cell Line Development3

Process Development3

Tech Transfer3

Analytical Development3

Portable CMC™3

mRNA therapeutics2

Medical2

mRNA manufacturing2

mRNA vaccines2

mRNA design2

Professional Services1

Service Industry1

Health Care1

Funding rounds participated in

$18M sweet spot round size

Most of their 7 investments are in rounds between $7M and $21M

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Therapeutics

Biopharma

Life Science

Date founded

2017

Investments made

W

Wheeler Bio, Inc. raised $31M on October 4, 2022

Investors: ATUM, Seagull Capital and Alloy Therapeutics, Inc

V

Vernal Biosciences raised $21M on June 2, 2022

Investors: Ampersand Capital Partners, ATUM and Alloy Therapeutics, Inc

T

Tegmine Therapeutics raised undisclosed on April 6, 2022

Investors: Alloy Therapeutics, Inc

m

mytide Therapeutics raised $7M on March 8, 2022

Investors: Trog Hawley Capital LLC, Uncommon Denominator and Alloy Therapeutics, Inc

W

Wheeler Bio, Inc. raised $14M on January 4, 2022

Investors: Presbyterian Health Foundation and Alloy Therapeutics, Inc

W

Wheeler Bio, Inc. raised undisclosed on July 21, 2021

Investors: Alloy Therapeutics, Inc

V

Vernal Biosciences raised undisclosed on July 12, 2021

Investors: VCET and Alloy Therapeutics, Inc